Yen-Michael Sheng Hsu is the founding director of the Laboratory for Advanced Cellular Therapy at Weill Cornell Medicine. While there, he oversaw the creation of a cGMP cellular therapy facility, the first of its kind.
Hsu also leads the Laboratory for Advanced Cellular Engineering at New York-Presbyterian Hospital. He holds leadership positions in the Foundation for the Accreditation of Cellular Therapy and AABB, two cellular therapy organizations.
“We are pleased to welcome Dr. Hsu to our Scientific and Clinical Advisory Board,” CEO David Jin said. “He has been an invaluable asset in our exosome-based clinical programs for liquid biopsy and regenerative therapeutics. He also brings a wealth of knowledge, experience and leadership in cellular therapy, and has an impressive track record in both translational and clinical research fields.”
Avalon is a Freehold, New Jersey-based CellTech bio-developer focused on advancing cellular therapeutics utilizing exosomes, vesicles that sit outside and operate between cells.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel